Literature DB >> 27477422

Successful Treatment of Aspergillus Empyema Using Open Window Thoracostomy Salvage Treatment and the Local Administration of an Antifungal Agent.

Nobuyuki Ashizawa1, Shigeki Nakamura, Shotaro Ide, Masato Tashiro, Takahiro Takazono, Yoshifumi Imamura, Taiga Miyazaki, Koichi Izumikawa, Yoshihiro Yamamoto, Katsunori Yanagihara, Yoshitsugu Miyazaki, Shigeru Kohno.   

Abstract

A 76-year-old woman received long-term immunosuppressive treatment for collagen vascular disease-associated interstitial pneumonia. The patient developed a cavitary mass lesion in the right lower lung field, and both nontuberculous mycobacteria and Aspergillus spp. were isolated after bronchial washing. The patient underwent a right lower lobectomy but developed Aspergillus empyema. Empyema due to Aspergillus spp. is a rare and life-threatening condition; however, the standard therapeutic strategies for treating Aspergillus empyema are not clear. We herein report a case of Aspergillus empyema that was successfully treated with a combination therapy which included open-window thoracostomy and the administration of antifungal agents (systemic micafungin and local amphotericin-B).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27477422     DOI: 10.2169/internalmedicine.55.6250

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  A young immunocompetent patient with spontaneous Aspergillus empyema who developed severe eosinophilia.

Authors:  Fumiaki Kudo; Hiromitsu Ohta; Yoshiaki Nagai; Kentaro Minegishi; Shinichiro Koyama
Journal:  Respir Med Case Rep       Date:  2017-08-30

2.  Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema.

Authors:  Atsushi Suzuki; Tomoki Kimura; Kensuke Kataoka; Toshiaki Matsuda; Toshiki Yokoyama; Yuta Mori; Yasuhiro Kondoh
Journal:  Respir Med Case Rep       Date:  2018-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.